TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 SEK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover | 243 | 411 | |
Financial expenses | 61 | 30 | |
Earnings before taxes | 2,053 | 108 | |
EBITDA | 16 | 100 | |
Total assets | 6,790 | 4,833 | |
Current assets | 6,369 | 4,351 | |
Current liabilities | 67 | 107 | |
Equity capital | 6,637 | 4,593 | |
- share capital | 100 | 100 | |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency | 97.7% | 95.0% | |
Turnover per employee | 243 | 411 | |
Profit as a percentage of turnover | 844.9% | 26.3% | |
Return on assets (ROA) | 31.1% | 2.9% | |
Current ratio | 9506.0% | 4066.4% | |
Return on equity (ROE) | 30.9% | 2.4% | |
Change turnover | -168 | -316 | |
Change turnover % | 57% | -41% | -43% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.